跳至主要内容
临床试验/KCT0003499
KCT0003499招募中未知

Proton pump inhibitor, bismuth, amoxicillin, and metronidazole as first-line therapy for Helicobacter pylori infection

Asan Medical Center0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 79(Year)(—)
性别
All

入选标准

  • Adults older than 19 and younger than 80 are eligible. Patients with peptic ulcer disease, gastric neoplasms, gastric MALT lymphoma, chronic gastritis with Helicobacter pylori infection are included in the study.

排除标准

  • Patients with previous Helicobacter pylori eradication therapy, patients with stomach or esophageal surgery, patients with pregnancy or lactation, patients with renal or hepatic dysfunction, patients with previous history of allergy or hypersensitivity reactions to drugs, patients with infectious mononucleosis, Patients with hematologic disorders, patients with nervous system disease are excluded.

研究者

相似试验

Unknown
4 期
PPI-amoxicillin for H. Pylori TreatmentHelicobacter Pylori Infection
NCT05014685Shanghai Zhongshan Hospital732
已完成
不适用
The Use of Proton Pump Inhibitors in General PracticeDigestive system diseases: Peptic ulcer diseaseDigestive SystemPeptic ulcer
ISRCTN70358598HS R&D Regional Programme Register - Department of Health (UK)
进行中(未招募)
不适用
Salvage chemotherapy with daily, low, continuously administered dose of capecitabine and proton-pump inhibitors in advanced gastro-intestinaltumours
EUCTR2013-001096-20-ITDepartment of Molecular and Clinical Medicine; Sapienza University of Rome
进行中(未招募)
1 期
PPI in walnut allergy
EUCTR2015-001863-38-ESFundación para la investigación biomedica del hospital clinico san carlos de madrid60
进行中(未招募)
1 期
PPI in secondary hemochromatosis.Iron overload (secondary hemochromatosis) in non-transfusion dependent forms of hereditary anemias. Iron overload and hereditary anemia are a growing, underestimated emerging health care problem.MedDRA version: 20.0Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851MedDRA version: 20.0Level: LLTClassification code 10057875Term: Secondary haemochromatosisSystem Organ Class: 100000004861MedDRA version: 20.0Level: HLTClassification code 10022979Term: Iron excessSystem Organ Class: 100000004861MedDRA version: 20.0Level: LLTClassification code 10055610Term: HemoglobinopathySystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10074356Term: Non-transfusion dependent thalassemiaSystem Organ Class: 100000004850
EUCTR2017-003777-34-NLMC Utrecht40